Lyka Labs Ltd

Know More
NSEBSE

124.35-3.00 (-2.36%)

12:00 AM,23rd Feb 2024

124.20-2.90 (-2.28%)

12:00 AM,23rd Feb 2024

BSE : 500259

NSE : LYKALABS

Sector : Health care

ISIN Code : INE933A01014

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Feb 23 2024 | 12:00 AM IST

Market Cap (₹ Cr)

411

Turnover (₹ Cr)

0.11

Volume (Shares)

84925

Face Value

10

52-WK High

144.30

52-WK High Date

08 Feb 2024

52-WK Low

88.50

52-WK Low Date

23 May 2023

All Time High

267.00

All Time High Date

24 Dec 2021

All Time Low

8.15

All Time Low Date

21 Dec 2011

Lyka Labs Ltd

Initially manufacturing formulations Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83. It also added a range of ayurvedic and animal health care products over the years. In 1990 it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson US; Airsep Corporation US; Coloplast Denmark; and Terumo Corporation Japan. Lyka Exports is the subsidiary of the company. The company offers a broad range of antibiotics used as life-savers and to treat minor infections. It has a fairly widespread product base with tropical steroids for skin disorders anti-cancer products cardio-vascular drugs and anti-inflammatory products. Lyka introduced in India cough lozenges containing dextromethorphan hydrobromide (DMR) favoured internationally as an effective and safe cough suppressant. Lyka has two formulations division and a bulk drugs division. It also set up additional manufacturing facilities for ointments. As part of its diversification it has invested in Relic Finance a company carrying on the business of finance and merchant banking.A GOI-recognised Export House it received the Certificate of Merit for its excellent export performance in 1993-94. In the same year it received an award from CHEMEXCIL for its outstanding performance.During 1997-98 the company's administrative office & plant at tarapur has been awarded ISO 9002 certification for its quality management system by SGS Yarsley International Certification Services Limited UK.The production carried out at Bombay has been shifted to Tarapur and Ankleshwar in the year 1999-2000 inorder to achieve economies of scale and better compliance. The company has assigned Trade Marks and transferred technical marketing know-how and allied rights pertaining to some of its products.

Lyka Labs Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

411

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

4.14

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]30.07
P/B Ratio (₹) [S]4.14
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Quant Active Fund (G) 8.67 841767 0.21
Quant Active Fund (IDCW) 8.67 841767 0.21
Quant Active Fund - Direct (G) 8.67 841767 0.21
Quant Active Fund - Direct (IDCW) 8.67 841767 0.21

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

124.05

128.50

Week Low/High

124.05

136.00

Month Low/High

114.10

144.00

Year Low/High

88.50

144.00

All time Low/High

8.46

267.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-3.94%-4.09%1.290.78%
1 Month7.11%5.83%4.244.59%
3 Month-10.22%-10.09%11.1212.17%
6 Month9.51%9.08%12.1114.24%
1 Year3.71%4.45%23.0726.85%
3 Year312.44%313.12%47.4551.03%

Company Info

Company Information

Chairman & MD & CEO : KUNAL NARENDRA GANDHI

Non-Exec. & Independent Dir. : Sandeep P Parikh

Executive Director & CFO : Yogesh B Shah

Non-Exec. & Independent Dir. : Dhara P. Shah

Company Sec. & Compli. Officer : Kishore P Shah

Independent Director : Babulal Jain

Director : Prashant Godha

Director : Shashil Mendonsa

Registered Office: 4801/B & 4802/A, GIDC Industrial Estate,Ankleshwar,Gujarat-393002 Ph: 91-02646-221422/220549

Email:companysecretary@lykalabs.com

URL:http://www.lykalabs.com